EMA Application withdrawn: Sildenafil FGK (sildenafil citrate) — FGK Representative Service GmbH

View source ↗

Summary

A regulatory application for sildenafil citrate (Sildenafil FGK) has been withdrawn by FGK Representative Service GmbH for erectile dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• Sildenafil FGK (sildenafil citrate)

Snippet

Status: Application withdrawn. Therapeutic area: Erectile Dysfunction. MAH: FGK Representative Service GmbH